The pro-tumor activity of IL-10 relied, at least in part, on the over-expression of SOCS-3 (Suppressor of Cytokine Signaling 3) that in turn inhibited the anti-tumoral IL-6 signaling pathway in macrophages co-cultured with metastatic tumor cells. The gene discussed is IL6; the disease is neoplasm.